Other substances

2-(Morpholin-4-yl)-2-oxoethyl 6-(4-methoxyphenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylate

A putative SARS-CoV-2 3C-like protease inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

2-(Morpholin-4-yl)-2-oxoethyl 6-(4-methoxyphenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylate on PubChem

Synonyms

ZINC03231196; ZINC3231196; Oprea1_159878

 

Structure image - 2-(Morpholin-4-yl)-2-oxoethyl 6-(4-methoxyphenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylate

CC1=NN(C2=C1C(=CC(=N2)C3=CC=C(C=C3)OC)C(=O)OCC(=O)N4CCOCC4)C5=CC=CC=C5

Supporting references

Link Tested on Impact factor Notes Publication date
Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening
3CLpro Small molecule In silico 		in silico 4.19

Predicted to inhibit SARS-CoV-2 3C-like protease.

 Dec/17/2020
Export (.csv)